PreveCeutical Medical Inc (18H) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.070x

Based on the latest financial reports, PreveCeutical Medical Inc (18H) has a cash flow conversion efficiency ratio of 0.070x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-520.46K ≈ $-608.47K USD) by net assets (€-7.39 Million ≈ $-8.64 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See PreveCeutical Medical Inc (18H) net asset quality to measure how much of total assets are equity-financed.

PreveCeutical Medical Inc - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how PreveCeutical Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 18H cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

PreveCeutical Medical Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PreveCeutical Medical Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Agereh Technologies Inc V:AUTO	0.039x
REDSUN PROPERTIES GROUP F:0RJ	N/A
EMPYREAN ENERGY LS-002 F:E1E	N/A
Immersion SA PA:ALIMR	0.089x
iSpecimen Inc NASDAQ:ISPC	-4.130x
Weaccess Group SA PA:MLWEA	0.230x
BPH Global Ltd AU:BP8	0.413x
CPD SA WAR:CPD	-0.023x

Annual Cash Flow Conversion Efficiency for PreveCeutical Medical Inc (2016–2024)

The table below shows the annual cash flow conversion efficiency of PreveCeutical Medical Inc from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see PreveCeutical Medical Inc (18H) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-6.64 Million ≈ $-7.76 Million	€-426.69K ≈ $-498.85K	0.064x	+25.09%
2023-12-31	€-5.78 Million ≈ $-6.76 Million	€-296.97K ≈ $-347.19K	0.051x	-47.18%
2022-12-31	€-4.64 Million ≈ $-5.42 Million	€-450.99K ≈ $-527.25K	0.097x	-6.35%
2021-12-31	€-4.10 Million ≈ $-4.80 Million	€-426.39K ≈ $-498.49K	0.104x	+679.67%
2020-12-31	€-3.60 Million ≈ $-4.21 Million	€64.59K ≈ $75.52K	-0.018x	-108.09%
2019-12-31	€-4.49 Million ≈ $-5.25 Million	€-993.94K ≈ $-1.16 Million	0.222x	-93.32%
2018-12-31	€-2.29 Million ≈ $-2.67 Million	€-7.57 Million ≈ $-8.85 Million	3.314x	-73.46%
2017-12-31	€-344.34K ≈ $-402.57K	€-4.30 Million ≈ $-5.03 Million	12.485x	+181.02%
2016-12-31	€-296.06K ≈ $-346.13K	€-1.32 Million ≈ $-1.54 Million	4.443x	--

About PreveCeutical Medical Inc

F:18H Germany Biotechnology

Market Cap

$3.34 Million

€2.85 Million EUR

Market Cap Rank

#29314 Global

#2544 in Germany

Share Price

€0.01

Change (1 day)

-54.55%

52-Week Range

€0.01 - €0.03

All Time High

€0.13